Precision medicine

Bottles of painkillers
#Painkillers #Precision medicine

Targeted painkillers could reduce side effects 

A University of Queensland spin-off company hopes to develop precision painkillers that are more accurate and less harmful to the liver. Professor Trent Munro, from the Australian Institute for Bioengineering and Nanotechnology (AIBN), is the scientific co-founder of Cassowary Pharmaceuticals, which is creating a new range of hyper-targeted… Read More

#News

Excitatory/inhibitory neuronal reporter
#Gene delivery #Gene expression #Gene therapy #Precision medicine #Proteins

Gene expression delivery tool ‘slides’ instructions into cells

Researchers say they have successfully used a cell’s natural process for making proteins to ‘slide’ genetic instructions into a cell and produce critical proteins missing from those cells.   If further studies verify the results, this could be a new method for targeting specific cell types for a… Read More

#News #Trending News

Neurons in the brain
#Antidepressants #Interview #Major depressive disorder #Neuropsychiatric disorders #Neuroscience #Precision medicine #Precision psychiatry #Psychiatry

Precision psychiatry: Transforming therapeutics for CNS disorders

Mike McCully, CEO of Gate Neurosciences, speaks to DDW’s Diana Spencer about the company’s pipeline of next-generation antidepressants and why this could be the most exciting time in the history of psychiatry. DS: How has our understanding of the brain developed in the last 70 years?  MM: Although our understanding… Read More

#Exclusive Content

#Biotechnology #Data #Precision medicine #Webinar

Webinar offers an insider’s view on computational drug discovery  

Collaborative Drug Discovery (CDD) is hosting a webinar in which CDD’s Eric Gifford speaks with two industry experts, Dr Josh Horan and Dr Michael Kappler about their experience working with data at biotech companies.   The live webinar will take place on December 1, 2022 at 8AM (PT), 11AM… Read More

#News

Protein molecule
#Biomarkers #Cancer #Diagnostics #Precision medicine #Proteomics

South Korean proteomics company Bertis expands to the US

Bertis, a South Korean proteomics-based precision medicine technology company, has established a US-based wholly-owned entity to expand its global presence. The subsidiary, called Bertis Bioscience, aims to establish a San Diego-based CLIA-certified lab facility in early Q4, 2022. It will offer proteomics-based screening and diagnostic tests, as well as an… Read More

#Cancer Research #News

#Diagnostics #Genomics #Personalised medicine #Precision medicine #Predictive diagnostics

Predictive diagnostics: closing the precision medicine gap

Listen to this article on the DDW podcast: Jarret Glasscock, PhD, CEO of Cofactor Genomics explains how diagnostics are emerging as the key to ensuring the right patients get matched to the right therapy, at the right time.  Precision medicine promises a paradigm shift to confidently match the right patients… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Precision medicine

What’s the next step in big data and AI?

Listen to this article on the DDW Podcast: Big data and AI are all the rage. But, beyond these buzzwords and the quantity of data, what’s next for these powerful tools? Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can… Read More

#Editor's Choice #Exclusive Content

Bacteria
#Antimicrobial resistance (AMR) #Boehringer Ingelheim #Precision medicine

Joint venture launches to fight antimicrobial resistance  

A new joint-venture has been formed between Evotec, Boehringer Ingelheim and bioMérieux in a bid to fight antimicrobial resistance (AMR) through the development of new antimicrobials and diagnostics.  Aurobac Therapeutics SAS will combine the expertise of its three founding companies and utilise a precision approach in the… Read More

#News

DNA
#AI #Multi-omics #Precision medicine

Partnership to advance precision medicine for metabolic disease  

Drug discovery company MultiOmic Health and digital health start-up Mesh Bio will work together on an observational clinical study for patients with chronic metabolic disease and increased risk of complications such as chronic kidney disease.   The partnership will provide access to data from patient populations in Asia… Read More

#News

#Appointment #Precision medicine

Iterative Scopes appoints new CTO  

Precision medicine technologies company Iterative Scopes has appointed a new Chief Technology Officer (CTO) to help lead the business’ machine learning offerings.   Dr Aditya Khosla has joined the team as CTO and as a member of Iterative Scopes’ board of directors. In his role as CTO, Dr Khosla will lead Iterative… Read More

#Business & Investment #News

#Appointment #Diversity #Pistoia Alliance #Precision medicine

Pistoia Alliance appoints first female president  

The Pistoia Alliance has appointed its first female President with Dr Becky Upton taking on the position, the organisation has announced.  Dr Upton will lead the not-the-profit’s strategy with a focus on areas of increasing importance such as data standards, diversity and inclusion, sustainability and precision medicine.  Dr Upton aims… Read More

#Business & Investment #News

#Clinical trials #IBD #Precision medicine

Iterative Scopes expands IBD offering with acquisitions  

Precision medicine technologies company Iterative Scopes has acquired two clinical trial optimisation companies focused on streamlining and accelerating the drug development process for inflammatory bowel disease (IBD).  The company has acquired Clinical Research Strategy Group, LLC and Precision Research (CRSG/Precision) in an effort to bolster its efforts… Read More

#News

#AAV #Biotechnology #Diabetes #Precision medicine

Collaboration to develop AAV vectors for diabetes gene therapy 

PerkinElmer’s SIRION Biotech business and the Centre for Genomic Regulation (CRG) have agreed to jointly develop new generation adeno-associated virus (AAV) vectors for Type 1 and Type 2 diabetes gene therapy in the pancreas.  The collaboration  The collaboration combines SIRION’s AAV technology platform and expertise… Read More

#News

#CRISPR #Drug discovery #Precision medicine #Therapeutics

Therapeutics: Changing the way we treat disease – podcast 

The latest free-to-listen DDW podcast episode is titled “Therapeutics: Changing the way we treat disease”. It covers two articles written for Volume 22, Issue 2 – Spring 2021 of the Drug Discovery World Magazine and has been narrated by DDW’s Megan Thomas.  These articles are titled: “Avoiding double strand breaks on… Read More

#News

#Biosciences #Cancer research #Drug development #Drug discovery #Oncology #Precision medicine

Anticancer Bioscience expands to Chinese biotech research park 

Anticancer Bioscience, a company developing synthetic lethal approaches to precision oncology, have relocated to Tianfu International Biotown, in Chengdu, China, to accommodate its growth and expansion, and on the back of its recent financing. Biotown is considered the premier biotech research park in Chengdu, the capital of Sichuan province.  The… Read More

#News

#Biotechnology #Drug development #Inflammatory Bowel Disease #Precision medicine

The start-up changing the game for IBD 

Jenny Bailey, CEO of Ferryx tells Lu Rahman how its leading product FX856 came to life and how it’s a game-changer for inflammatory bowel disease since it can act during active inflammation.  Ferryx is an innovative bio-tech start-up. It is a University of Bristol spin-out with a focus on gut health and IBD in… Read More

#Editor's Choice #Exclusive Content #Intelligence #News #Opinion #Start-up Zone #Trends & Analysis